Our Peptide and Oligonucleotide Editorial Focus eBook offers a curated collection of forward-thinking research, expert commentary, and clinical developments that are reshaping the way targeted therapies are designed, delivered, and manufactured.
Download the full eBook
From next-gen peptide engineering to the expanding potential of RNA-based treatments, the eBook explores the molecular innovations driving a new era in precision medicine.
Inside, you'll find in-depth coverage of key advances in intracellular delivery, regenerative bioactive peptides, and emerging therapeutic pathways, all of which are propelling progress in areas such as metabolic disease, bone health, and complex biologics.
This eBook also takes a closer look at how the evolving biopharma landscape is responding to rising demand for molecules such as GLP-1, spotlighting new production strategies and analytical approaches that can help manufacturers meet both clinical needs and market expectations.
Analytical rigor is a recurring theme throughout. High-field NMR spectroscopy stands out as a critical tool for structural analysis, quality control, and impurity profiling across both peptides and oligonucleotides.
With practical how-to guides, real-world case studies, and application-driven insights, this Editorial Focus is a valuable resource for scientists, researchers, and biopharma professionals working at the forefront of therapeutic innovation.
Download your free copy to stay informed on the science and strategy shaping the next generation of advanced medicines.
Download the full eBook
About Bruker BioSpin Group
The Bruker BioSpin Group designs, manufactures, and distributes advanced scientific instruments based on magnetic resonance and preclinical imaging technologies. These include our industry-leading NMR and EPR spectrometers, as well as imaging systems utilizing MRI, PET, SPECT, CT, Optical and MPI modalities. The Group also offers integrated software solutions and automation tools to support digital transformation across research and quality control environments.
Bruker BioSpin’s customers in academic, government, industrial, and pharmaceutical sectors rely on these technologies to gain detailed insights into molecular structure, dynamics, and interactions. Our solutions play a key role in structural biology, drug discovery, disease research, metabolomics, and advanced materials analysis. Recent investments in lab automation, optical imaging, and contract research services further strengthen our ability to support evolving customer needs and enable scientific innovation.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices, and treatments.